Insider transactions

EDGAR

Outlook Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
10 transactions, 12,003,058 shares
Sum of shares × price per share: 7,867,771.5013 2 without a price are not valued.
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–22 of 22

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-01 Filed 2026-09-02Lundquist Kevin Michael Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Employee Stock Option (Right to Buy) — underlying Common Stock (500,000) — exercise price 0.63
Acquired (A)500,0000—500,000Direct (D) No
F1
  • F1 The option was granted by Outlook Therapeutics, Inc. (the Issuer) as an inducement material to the Reporting Person's entry into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). 25% of the shares subject to the option shall vest on September 1, 2027, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date.
Open filing 0002074701-26-000005 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-14KENYON LAWRENCE A Director · Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)101,010——106,956Direct (D) No
F1
  • F1 On August 14, 2026, the reporting person acquired 101,010 shares of common stock and accompanying warrants to purchase 101,010 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant.
Open filing 0001649989-26-000009 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-14KENYON LAWRENCE A Director · Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants (right to buy) — underlying Common Stock (101,010) — exercise price 1.1
Acquired (A)101,010——101,010Direct (D) No
F2, F1
  • F2 The warrants were exercisable immediately upon issuance and expire five years from the date of issuance, on August 14, 2031.
  • F1 On August 14, 2026, the reporting person acquired 101,010 shares of common stock and accompanying warrants to purchase 101,010 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant.
Open filing 0001649989-26-000009 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-14Jahr Robert Charles Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)151,515——151,515Direct (D) No
F1
  • F1 On August 14, 2026, the reporting person acquired 151,515 shares of common stock and accompanying warrants to purchase 151,515 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant.
Open filing 0001104659-26-097406 Read from the filing’s XML Dispute this row
2026-08-14 Filed 2026-08-14Jahr Robert Charles Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants (right to buy) — underlying Common Stock (151,515) — exercise price 1.10
Acquired (A)151,515——151,515Direct (D) No
F2, F1
  • F2 The warrants were exercisable immediately upon issuance and expire five years from the date of issuance, on August 14, 2031.
  • F1 On August 14, 2026, the reporting person acquired 151,515 shares of common stock and accompanying warrants to purchase 151,515 shares of common stock in the Issuer's underwritten public offering of shares of common stock and accompanying warrants for a combined public offering price of $0.99 per share of common stock and accompanying warrant.
Open filing 0001104659-26-097406 Read from the filing’s XML Dispute this row
2026-08-12 Filed 2026-08-14Sukhtian Ghiath M. Director · 10% ownerGMS Ventures Investments Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)2,525,2520.99
2,499,999.48

Derived: shares × price per share. Exact value 2499999.48.

24,617,320Indirect (I) See footnoteNo
F1, F3, F4
  • F1 On August 12, 2026, the Issuer entered into an underwriting agreement with Piper Sandler Co. and BTIG, LLC, as representatives of the several underwriters named therein, relating to an underwritten public offering by the Issuer of shares of its common stock and accompanying warrants to purchase shares of common stock at a combined public offering price of $0.99 per share of common stock and accompanying warrant. The offering closed on August 14, 2026. The price reported in Table I above represents the combined public offering price for one share of common stock and one accompanying warrant to purchase one share of common stock; no separate consideration was paid for the accompanying warrants, and accordingly the price of the derivative security reported in Table II above is $0.00.
  • F3 These securities are held of record by GMS Ventures. Ghiath M. Sukhtian (Ghiath Sukhtian), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.
  • F4 By virtue of the relationships described above in Footnote 3, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owners of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0000899140-26-000894 Read from the filing’s XML Dispute this row
2026-08-12 Filed 2026-08-14Sukhtian Ghiath M. Director · 10% ownerGMS Ventures Investments Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants (right to buy) — underlying Common Stock (2,525,252) — exercise price 1.10
Acquired (A)2,525,2520—2,525,252Indirect (I) See footnoteNo
F1, F2, F3, F4
  • F1 On August 12, 2026, the Issuer entered into an underwriting agreement with Piper Sandler Co. and BTIG, LLC, as representatives of the several underwriters named therein, relating to an underwritten public offering by the Issuer of shares of its common stock and accompanying warrants to purchase shares of common stock at a combined public offering price of $0.99 per share of common stock and accompanying warrant. The offering closed on August 14, 2026. The price reported in Table I above represents the combined public offering price for one share of common stock and one accompanying warrant to purchase one share of common stock; no separate consideration was paid for the accompanying warrants, and accordingly the price of the derivative security reported in Table II above is $0.00.
  • F2 The warrants were exercisable immediately upon issuance and expire five years from the date of issuance, on August 14, 2031. The warrants are subject to a beneficial ownership limitation that prohibits exercise to the extent the holder, together with its affiliates and other attribution parties, would beneficially own more than the applicable percentage of the Issuer's outstanding common stock immediately after giving effect to such exercise.
  • F3 These securities are held of record by GMS Ventures. Ghiath M. Sukhtian (Ghiath Sukhtian), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.
  • F4 By virtue of the relationships described above in Footnote 3, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owners of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0000899140-26-000894 Read from the filing’s XML Dispute this row
2026-07-29 Filed 2026-07-29Sukhtian Faisal Ghiath Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)95,3981.0482
99,996.1836

Derived: shares × price per share. Exact value 99996.1836.

220,972Direct (D) No— Open filing 0001649989-26-000008 Read from the filing’s XML Dispute this row
2026-07-21 Filed 2026-07-23Jahr Robert Charles Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (100,000) — exercise price 1.4304
Acquired (A)100,0000—100,000Direct (D) No
F1
  • F1 The option was granted to Mr. Jahr on July 21, 2026, pursuant to the Issuer's 2024 Equity Incentive Plan and the Issuer's standard form of stock option agreement thereunder. The option vests and becomes exercisable in full on July 21, 2027, subject to Mr. Jahr's continuing service with the Issuer through such vesting date.
Open filing 0001649989-26-000006 Read from the filing’s XML Dispute this row
2026-07-21 Filed 2026-07-23KENYON LAWRENCE A Director · Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (210,078) — exercise price 1.4304
Acquired (A)210,0780—210,078Direct (D) No
F1
  • F1 The option was granted to Mr. Kenyon on July 21, 2026, pursuant to the Issuer's 2024 Equity Incentive Plan and the Issuer's standard form of stock option agreement thereunder. The option vests and becomes exercisable in full on July 21, 2027, subject to Mr. Kenyon's continuing service with the Issuer through such vesting date.
Open filing 0001649989-26-000007 Read from the filing’s XML Dispute this row
2026-06-02 Filed 2026-06-03Haddadin Yezan Munther Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)29,0000.8326
24,145.4

Derived: shares × price per share. Exact value 24145.4000.

66,167Direct (D) No— Open filing 0001649989-26-000005 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-01Sukhtian Ghiath M. Director · 10% ownerGMS Ventures Investments Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)8,539,7090.5855
4,999,999.6195

Derived: shares × price per share. Exact value 4999999.6195.

22,092,068Indirect (I) See footnoteNo
F1, F2, F3
  • F1 On May 28, 2026, GMS Ventures and Investments (GMS Ventures) entered into a securities purchase agreement with Outlook Therapeutics, Inc. (the Issuer) pursuant to which the Issuer agreed to issue and sell 8,539,709 shares of the Issuer's common stock at $0.5855 per share in a registered direct offering for a total purchase price of approximately $5.0 million.
  • F2 These securities are held of record by GMS Ventures. Ghiath M. Sukhtian (Ghiath Sukhtian), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.
  • F3 By virtue of the relationships described above in Footnote 2, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owners of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0000899140-26-000620 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-01Sukhtian Ghiath M. Director · 10% ownerGMS Ventures Investments Director · 10% owner
H

Expiration (or cancellation) of long derivative position with value received

Derivative security: Warrants (right to buy) — underlying Common Stock (3,458,571) — exercise price 2.26
Disposed (D)3,458,571——0Indirect (I) See footnoteNo
F4, F2, F3
  • F4 The transactions reported in Table II above involved the amendment of the outstanding Tranche A warrants issued on January 16, 2025 to reduce the exercise price from $2.26 per share to $0.5855 per share. The amendment is reported above as the cancellation of the old warrant and the acquisition of a new one.
  • F2 These securities are held of record by GMS Ventures. Ghiath M. Sukhtian (Ghiath Sukhtian), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.
  • F3 By virtue of the relationships described above in Footnote 2, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owners of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0000899140-26-000620 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-01Sukhtian Ghiath M. Director · 10% ownerGMS Ventures Investments Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants (right to buy) — underlying Common Stock (3,458,571) — exercise price 0.5855
Acquired (A)3,458,571——3,458,571Indirect (I) See footnoteNo
F4, F2, F3
  • F4 The transactions reported in Table II above involved the amendment of the outstanding Tranche A warrants issued on January 16, 2025 to reduce the exercise price from $2.26 per share to $0.5855 per share. The amendment is reported above as the cancellation of the old warrant and the acquisition of a new one.
  • F2 These securities are held of record by GMS Ventures. Ghiath M. Sukhtian (Ghiath Sukhtian), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.
  • F3 By virtue of the relationships described above in Footnote 2, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owners of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0000899140-26-000620 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-01Sukhtian Ghiath M. Director · 10% ownerGMS Ventures Investments Director · 10% owner
H

Expiration (or cancellation) of long derivative position with value received

Derivative security: Warrants (right to buy) — underlying Common Stock (3,458,571) — exercise price 2.26
Disposed (D)3,458,571——0Indirect (I) See footnoteNo
F5, F2, F3
  • F5 The transactions reported in Table II above involved the amendment of the outstanding Tranche B warrants issued on January 16, 2025 to reduce the exercise price from $2.26 per share to $0.5855 per share. The amendment is reported above as the cancellation of the old warrant and the acquisition of a new one.
  • F2 These securities are held of record by GMS Ventures. Ghiath M. Sukhtian (Ghiath Sukhtian), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.
  • F3 By virtue of the relationships described above in Footnote 2, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owners of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0000899140-26-000620 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-01Sukhtian Ghiath M. Director · 10% ownerGMS Ventures Investments Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants (right to buy) — underlying Common Stock (3,458,571) — exercise price 0.5855
Acquired (A)3,458,571——3,458,571Indirect (I) See footnoteNo
F5, F2, F3
  • F5 The transactions reported in Table II above involved the amendment of the outstanding Tranche B warrants issued on January 16, 2025 to reduce the exercise price from $2.26 per share to $0.5855 per share. The amendment is reported above as the cancellation of the old warrant and the acquisition of a new one.
  • F2 These securities are held of record by GMS Ventures. Ghiath M. Sukhtian (Ghiath Sukhtian), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.
  • F3 By virtue of the relationships described above in Footnote 2, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owners of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0000899140-26-000620 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-01Sukhtian Ghiath M. Director · 10% ownerGMS Ventures Investments Director · 10% owner
H

Expiration (or cancellation) of long derivative position with value received

Derivative security: Warrants (right to buy) — underlying Common Stock (8,571,428) — exercise price 1.4
Disposed (D)8,571,428——0Indirect (I) See footnoteNo
F6, F2, F3
  • F6 The transactions reported in Table II above involved the amendment of the outstanding warrants issued on May 27, 2025 to reduce the exercise price from $1.40 per share to $0.5855 per share. The amendment is reported above as the cancellation of the old warrant and the acquisition of a new one.
  • F2 These securities are held of record by GMS Ventures. Ghiath M. Sukhtian (Ghiath Sukhtian), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.
  • F3 By virtue of the relationships described above in Footnote 2, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owners of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0000899140-26-000620 Read from the filing’s XML Dispute this row
2026-05-28 Filed 2026-06-01Sukhtian Ghiath M. Director · 10% ownerGMS Ventures Investments Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Derivative security: Warrants (right to buy) — underlying Common Stock (8,571,428) — exercise price 0.5855
Acquired (A)8,571,428——8,571,428Indirect (I) See footnoteNo
F6, F2, F3
  • F6 The transactions reported in Table II above involved the amendment of the outstanding warrants issued on May 27, 2025 to reduce the exercise price from $1.40 per share to $0.5855 per share. The amendment is reported above as the cancellation of the old warrant and the acquisition of a new one.
  • F2 These securities are held of record by GMS Ventures. Ghiath M. Sukhtian (Ghiath Sukhtian), a natural person, is the holder of a controlling interest in GMS Ventures. GMS Ventures has designated two representatives to serve on the Issuer's board of directors. Therefore, each of GMS Ventures and Ghiath Sukhtian may be deemed a director by deputization.
  • F3 By virtue of the relationships described above in Footnote 2, Ghiath Sukhtian may be deemed to have voting and investment power with respect to the securities held by GMS Ventures noted above and as a result may be deemed to beneficially own such securities for purposes of Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the Exchange Act). The Reporting Persons disclaim beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons are the beneficial owners of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0000899140-26-000620 Read from the filing’s XML Dispute this row
2026-05-27 Filed 2026-05-27Sukhtian Faisal Ghiath Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)122,1740.4093
50,005.8182

Derived: shares × price per share. Exact value 50005.8182.

125,574Direct (D) No— Open filing 0001649989-26-000004 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-27HILZINGER KURT J Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)400,0000.4413
176,520

Derived: shares × price per share. Exact value 176520.0000.

423,655Direct (D) No— Open filing 0001649989-26-000001 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-27Haddadin Yezan Munther Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)34,0000.44
14,960

Derived: shares × price per share. Exact value 14960.00.

37,167Direct (D) No— Open filing 0001649989-26-000003 Read from the filing’s XML Dispute this row
2026-05-26 Filed 2026-05-27THURMAN RANDY H Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,0000.429
2,145

Derived: shares × price per share. Exact value 2145.000.

5,593Direct (D) No— Open filing 0001649989-26-000002 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–50 of 94

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
Empery Asset Management, LP 21,247,856 SH12,185,645 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-008014 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 8,976,833 SH5,152,702 dollarsHigher by 4,599,961 Prior quarter: 4,376,872Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager8,023,703 SH4,573,512 dollarsHigher by 6,036,125 Prior quarter: 1,987,578Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager5,050,505 SH2,896,466 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager3,343,234 SH1,919,016 dollarsHigher by 3,191,019 Prior quarter: 152,215Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
PERCEPTIVE ADVISORS LLC 3,139,216 SH1,800,340 dollarsUnchanged Prior quarter: 3,139,216Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,716,408 SH984,728 dollarsHigher by 470,540 Prior quarter: 1,245,868Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
BlackRock, Inc. Partly reported under another manager1,667,775 SH956,469 dollarsLower by 804 Prior quarter: 1,668,579Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
TWO SIGMA INVESTMENTS, LP 1,634,105 SH937,159 dollarsNot in the prior quarter’s filings read Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager1,422,923 SH816,046 dollarsHigher by 454,733 Prior quarter: 968,190Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager1,120,688 SH642,715 dollarsNot in the prior quarter’s filings read Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
VANGUARD FIDUCIARY TRUST CO 1,067,919 SH612,986 dollarsHigher by 406,255 Prior quarter: 661,664Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
GILPIN WEALTH MANAGEMENT, LLC 625,000 SH358,438 dollarsHigher by 70,000 Prior quarter: 555,000Open filing 0002058144-26-000008 Filed 2026-10-09 Dispute this row
STATE STREET CORP Partly reported under another manager569,702 SH326,724 dollarsHigher by 29,900 Prior quarter: 539,802Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager409,661 SH234,941 dollarsHigher by 172,100 Prior quarter: 237,561Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
Hudson Bay Capital Management LP 383,687 SH220,044 dollarsNot in the prior quarter’s filings read Open filing 0001393825-26-000083 Filed 2026-11-13 Dispute this row
GSA CAPITAL PARTNERS LLP 368,909 SH212 dollarsNot in the prior quarter’s filings read Open filing 0001362033-26-000013 Filed 2026-11-16 Dispute this row
RAYMOND JAMES FINANCIAL INC Partly reported under another manager332,051 SH190,431 dollarsUnchanged Prior quarter: 332,051Open filing 0000720005-26-000081 Filed 2026-11-12 Dispute this row
CITIGROUP INC Partly reported under another manager221,657 SH127,120 dollarsHigher by 220,892 Prior quarter: 765Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row
CANTOR FITZGERALD, L. P. Partly reported under another manager220,513 SH126,464 dollarsLower by 229,487 Prior quarter: 450,000Open filing 0000929638-26-004323 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Put Partly reported under another manager205,900 SH117,363 dollarsHigher by 26,700 Prior quarter: 179,200Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Option: Put Partly reported under another manager202,100 SH115,904 dollarsLower by 24,500 Prior quarter: 226,600Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Persistent Asset Partners Ltd 198,655 SH113,928 dollarsNot in the prior quarter’s filings read Open filing 0002056052-26-000005 Filed 2026-11-13 Dispute this row
SIMPLEX TRADING, LLC Option: Call 193,000 SH110,685 dollarsHigher by 63,100 Prior quarter: 129,900Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
CITADEL ADVISORS LLC Option: Call Partly reported under another manager189,300 SH108,564 dollarsHigher by 22,200 Prior quarter: 167,100Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
WINTON GROUP Ltd 188,282 SH107,980 dollarsNot in the prior quarter’s filings read Open filing 0001612063-26-000014 Filed 2026-11-12 Dispute this row
JANE STREET GROUP, LLC Option: Call Partly reported under another manager159,400 SH91,416 dollarsLower by 14,900 Prior quarter: 174,300Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager158,648 SH90,985 dollarsLower by 1,266,622 Prior quarter: 1,425,270Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
CITADEL ADVISORS LLC 138,818 SH79,612 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
GROUP ONE TRADING LLC Option: Call 137,100 SH78,627 dollarsHigher by 70,600 Prior quarter: 66,500Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
TUDOR INVESTMENT CORP ET AL 132,217 SH75,826 dollarsNot in the prior quarter’s filings read Open filing 0000902664-26-004567 Filed 2026-11-16 Dispute this row
Caption Management, LLC Option: Call 124,500 SH71,401 dollarsNot in the prior quarter’s filings read Open filing 0001706766-26-000008 Filed 2026-11-16 Dispute this row
Royal Fund Management, LLC 111,415 SH63,897 dollarsHigher by 64,215 Prior quarter: 47,200Open filing 0001172661-26-004648 Filed 2026-10-22 Dispute this row
GILPIN WEALTH MANAGEMENT, LLC Option: Call 100,000 PRN57,350 dollarsUnchanged Prior quarter: 100,000Open filing 0002058144-26-000008 Filed 2026-10-09 Dispute this row
Jefferies Financial Group Inc. Partly reported under another manager62,500 SH35,844 dollarsUnchanged Prior quarter: 62,500Open filing 0000096223-26-000034 Filed 2026-11-05 Dispute this row
NewEdge Advisors, LLC 60,669 SH34,794 dollarsHigher by 43,947 Prior quarter: 16,722Open filing 0001213900-26-119695 Filed 2026-11-13 Dispute this row
LPL Financial LLC 54,283 SH31,131 dollarsLower by 130,659 Prior quarter: 184,942Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row
Christensen, King Associates Investment Services, Inc. 54,066 SH31,007 dollarsHigher by 25,739 Prior quarter: 28,327Open filing 0002032544-26-000005 Filed 2026-10-22 Dispute this row
Corient Private Wealth LP 50,300 SH28,847 dollarsHigher by 15,200 Prior quarter: 35,100Open filing 0001948780-26-000012 Filed 2026-11-16 Dispute this row
Flower City Capital 50,000 SH28,675 dollarsHigher by 30,000 Prior quarter: 20,000Open filing 0001808394-26-000007 Filed 2026-10-15 Dispute this row
MAI Capital Management 50,000 SH28,675 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-004965 Filed 2026-11-12 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager49,300 SH28,101 dollarsLower by 492,900 Prior quarter: 542,200Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager45,069 SH25,847 dollarsHigher by 28,113 Prior quarter: 16,956Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Vanguard Global Advisers, LLC 41,137 SH23,613 dollarsUnchanged Prior quarter: 41,137Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row
HARBOUR INVESTMENTS, INC. 40,812 SH23,406 dollarsHigher by 28,508 Prior quarter: 12,304Open filing 0000810121-26-000006 Filed 2026-11-09 Dispute this row
GROUP ONE TRADING LLC 36,349 SH20,846 dollarsLower by 210,079 Prior quarter: 246,428Open filing 0000932540-26-000017 Filed 2026-11-10 Dispute this row
Warberg Asset Management LLC 35,177 SH20,174 dollarsNot in the prior quarter’s filings read Open filing 0001597506-26-000004 Filed 2026-11-02 Dispute this row
DIADEMA PARTNERS LP 35,000 SH20,073 dollarsNot in the prior quarter’s filings read Open filing 0001892688-26-000170 Filed 2026-11-16 Dispute this row
Cerity Partners LLC 34,691 SH19,895 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005020 Filed 2026-11-13 Dispute this row
JANE STREET GROUP, LLC Option: Put Partly reported under another manager33,800 SH19,384 dollarsLower by 24,000 Prior quarter: 57,800Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • HRT FINANCIAL LP 784,904 SH
  • Sanctuary Advisors, LLC 344,529 SH
  • SIMPLEX TRADING, LLC 205,013 SH
  • Wealth Management Partners, LLC 118,170 SH
  • MILLENNIUM MANAGEMENT LLC 57,839 SH
  • Tower Research Capital LLC (TRC) 57,391 SH
  • Belvedere Trading LLC 40,899 SH
  • Steward Partners Investment Advisory, LLC 29,500 SH
  • Signet Private Wealth LLC 17,555 SH
  • SG Americas Securities, LLC 17,271 SH
  • TWO SIGMA SECURITIES, LLC 14,855 SH
  • Caitong International Asset Management Co., Ltd 7,324 SH
  • Belvedere Trading LLC 5,000 SH
  • Integrated Wealth Concepts LLC 1,000 SH
  • MERCER GLOBAL ADVISORS INC /ADV 200 SH
  • Quarry LP 176 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
CVI Investments, Inc. Common Stock, $0.01 par value per share7.921,000,00009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001649553-26-000131 Dispute this row
Heights Capital Management, Inc. Common Stock, $0.01 par value per share7.921,000,00009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001649553-26-000131 Dispute this row
Empery Asset Management, LP Common Stock, $0.01 par value per share8.7321,247,856.0009/30/2026 Filed 2026-10-13SCHEDULE 13GOpen filing 0000919574-26-006871 Dispute this row
Ryan M. Lane Common Stock, $0.01 par value per share8.7321,247,856.0009/30/2026 Filed 2026-10-13SCHEDULE 13GOpen filing 0000919574-26-006871 Dispute this row
CVI Investments, Inc. Common Stock, $0.01 par value per share9.924,713,90808/12/2026 Filed 2026-08-19SCHEDULE 13GOpen filing 0001649553-26-000111 Dispute this row
Heights Capital Management, Inc. Common Stock, $0.01 par value per share9.924,713,90808/12/2026 Filed 2026-08-19SCHEDULE 13GOpen filing 0001649553-26-000111 Dispute this row
GMS Ventures Investments Common Stock, par value $0.01 per share16.442,631,14208/12/2026 Filed 2026-08-14SCHEDULE 13D/AAmendment 7Open filing 0000899140-26-000895 Dispute this row
SUKHTIAN GHIATH M. Common Stock, par value $0.01 per share16.442,631,14208/12/2026 Filed 2026-08-14SCHEDULE 13D/AAmendment 7Open filing 0000899140-26-000895 Dispute this row
GMS Ventures Investments Common Stock, par value $0.01 per share22.937,580,63805/28/2026 Filed 2026-06-01SCHEDULE 13D/AAmendment 6Open filing 0000899140-26-000621 Dispute this row
SUKHTIAN GHIATH M. Common Stock, par value $0.01 per share22.937,580,63805/28/2026 Filed 2026-06-01SCHEDULE 13D/AAmendment 6Open filing 0000899140-26-000621 Dispute this row
Mitchell P. Kopin Common Stock, par value $0.01 per share4.995,990,447.0004/22/2026 Filed 2026-04-24SCHEDULE 13GOpen filing 0001213900-26-047616 Dispute this row
Daniel B. Asher Common Stock, par value $0.01 per share4.995,990,447.0004/22/2026 Filed 2026-04-24SCHEDULE 13GOpen filing 0001213900-26-047616 Dispute this row
Intracoastal Capital LLC Common Stock, par value $0.01 per share4.995,990,447.0004/22/2026 Filed 2026-04-24SCHEDULE 13GOpen filing 0001213900-26-047616 Dispute this row
Sphera Funds Management Ltd. Common Stock, par value $0.01 per share4.693,153,85612/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 2Open filing 0001178913-26-000311 Dispute this row
Sphera Global Healthcare GP Ltd. Common Stock, par value $0.01 per share4.693,153,85612/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 2Open filing 0001178913-26-000311 Dispute this row
Sphera Global Healthcare Management LP. Common Stock, par value $0.01 per share4.693,153,85612/31/2025 Filed 2026-02-05SCHEDULE 13G/AAmendment 2Open filing 0001178913-26-000311 Dispute this row
Empery Asset Management, LP Common Stock, $0.01 par value per share4.992,332,948.0009/30/2025 Filed 2025-10-21SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-004475 Dispute this row
Ryan M. Lane Common Stock, $0.01 par value per share4.992,332,948.0009/30/2025 Filed 2025-10-21SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-004475 Dispute this row
Martin D. Hoe Common Stock, $0.01 par value per share4.992,332,948.0009/30/2025 Filed 2025-10-21SCHEDULE 13G/AAmendment 1Open filing 0000902664-25-004475 Dispute this row
Great Point Partners, LLC Common Stock, $0.001 par value per share4.992,220,000.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 4Open filing 0001172661-25-003535 Dispute this row
Dr. Jeffrey R. Jay, M.D. Common Stock, $0.001 par value per share4.992,220,000.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 4Open filing 0001172661-25-003535 Dispute this row
Ms. Lillian Nordahl Common Stock, $0.001 par value per share4.992,220,000.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 4Open filing 0001172661-25-003535 Dispute this row
TANG CAPITAL MANAGEMENT, LLC Common Stock, par value $0.01 per share3.41,500,000.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001214659-25-012269 Dispute this row
KEVIN TANG Common Stock, par value $0.01 per share3.41,500,000.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001214659-25-012269 Dispute this row
TANG CAPITAL PARTNERS, LP Common Stock, par value $0.01 per share3.41,500,000.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001214659-25-012269 Dispute this row
TANG CAPITAL PARTNERS INTERNATIONAL, LP Common Stock, par value $0.01 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001214659-25-012269 Dispute this row
TANG CAPITAL PARTNERS III, INC Common Stock, par value $0.01 per share00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001214659-25-012269 Dispute this row
TANG CAPITAL PARTNERS IV, INC Common Stock, par value $0.01 per share0.00.0006/30/2025 Filed 2025-08-14SCHEDULE 13G/AAmendment 3Open filing 0001214659-25-012269 Dispute this row
Empery Asset Management, LP Common Stock, $0.01 par value per share7.573,195,641.0006/30/2025 Filed 2025-07-31SCHEDULE 13GOpen filing 0000902664-25-003290 Dispute this row
Ryan M. Lane Common Stock, $0.01 par value per share7.573,195,641.0006/30/2025 Filed 2025-07-31SCHEDULE 13GOpen filing 0000902664-25-003290 Dispute this row
Martin D. Hoe Common Stock, $0.01 par value per share7.573,195,641.0006/30/2025 Filed 2025-07-31SCHEDULE 13GOpen filing 0000902664-25-003290 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,649,595 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201566,682
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,123

Filings made before the SEC required XML are listed, not extracted.

Back to Outlook Therapeutics, Inc.